Nov. 22, 2024 (GLOBE NEWSWIRE) -- Elevai Labs Inc. (NASDAQ: ELAB) (Elevai" or the "Company") announced today it will implement a 1-for-200 reverse stock split (“Reverse Stock Split”) of its ...

The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on November 26, 2024 (the “Effective Time”). The Common Stock will continue to trade on The Nasdaq Capital Market under ...

Globalstar (GSAT) announced its intent to transfer its common stock listing to Nasdaq in the first quarter of 2025. In connection with this planned uplisting, the company also announced that its ...

Inc. (Nasdaq: FTCI) (“FTC Solar”), a leading provider of solar tracker systems, today announced that it will implement a reverse stock split of its issued and outstanding Common Stock at a ...

The Company’s stockholders previously approved the reverse stock split and granted ... s shares will begin trading on a split-adjusted basis on the Nasdaq Capital Market commencing upon market ...

The Company’s Ordinary Shares are expected to begin trading on a Reverse Stock Split adjusted basis on Nasdaq as of the open of trading on December 4, 2024, under the existing ticker symbol ...

CRANFORD, N.J., Nov. 22, 2024 /PRNewswire/ -- Citius Pharmaceuticals, Inc. ("Citius Pharma" or the "Company") (Nasdaq: CTXR) announced today that it will be executing a reverse stock split of its ...

The reverse stock split is intended, among other things ... requirement of $1.00 per share for continued listing on The Nasdaq Global Market. When the reverse stock split becomes effective ...

The Reverse Stock Split will become effective at 12:01 a.m. Eastern Time on November 18, 2024, and the Company’s common stock will open for trading on The Nasdaq Capital Market on a post-split ...

announces a 1-for-15 reverse stock split of its Nasdaq-listed shares to meet listing standards. This strategic move reduces the outstanding shares significantly from 42.2 million to 2.8 million ...

This move aims to increase the per share trading price to enable the firm to satisfy the minimum bid price requirement for continued listing on the Nasdaq. The 1-for-33 reverse stock split will ...

The reverse stock split aims to boost the company’s share price to comply with Nasdaq’s minimum bid requirements. This proactive measure seeks to secure Mainz Biomed’s continuous listing on ...